We are live on ! Find out more
AI

Analytic Investors Portfolio holdings

AUM $8.93B
1-Year Est. Return 13.54%
This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+13.54%
3 Year Est. Return
+42.14%
5 Year Est. Return
10 Year Est. Return
AUM
$6.57B
AUM Growth
+$536M
Cap. Flow
+$353M
Cap. Flow %
5.37%
Top 10 Hldgs %
20.82%
Holding
665
New
181
Increased
125
Reduced
203
Closed
118

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$61.5M
2
AZO icon
AutoZone
AZO
+$57.7M
3
SYY icon
Sysco
SYY
+$44.3M
4
TGT icon
Target
TGT
+$41.7M
5
CSCO icon
Cisco
CSCO
+$35.4M

Sector Composition

Rank Sector Weight
1 Consumer Staples 19.41%
2 Healthcare 17.56%
3 Financials 11.47%
4 Technology 9.26%
5 Communication Services 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMO icon
226
Bank of Montreal
BMO
$126B
$2.76M 0.04%
41,200
-1,700
-4% -$110K
FSS icon
227
Federal Signal
FSS
$7.14B
$2.76M 0.04%
185,184
-1,404
-0.8% -$19.1K
TRI icon
228
Thomson Reuters
TRI
$45.7B
$2.69M 0.04%
67,729
+61,956
+1,073% +$2.54M
DST
229
DELISTED
DST Systems Inc.
DST
$2.64M 0.04%
55,740
-9,486
-15% -$442K
EAT icon
230
Brinker International
EAT
$8.46B
$2.64M 0.04%
50,329
-529,912
-91% -$26.5M
ALOG
231
DELISTED
Analogic Corp
ALOG
$2.62M 0.04%
31,934
+16,532
+107% +$1.48M
BOKF icon
232
BOK Financial
BOKF
$8.65B
$2.52M 0.04%
36,546
-2,230
-6% -$146K
CI icon
233
Cigna
CI
$79.1B
$2.47M 0.04%
29,546
-250
-0.8% -$20.6K
SGEN
234
DELISTED
Seagen Inc. Common Stock
SGEN
$2.42M 0.04%
53,156
+41,301
+348% +$1.98M
TECD
235
DELISTED
Tech Data Corp
TECD
$2.39M 0.04%
39,272
-36,858
-48% -$2.04M
INSY
236
DELISTED
Insys Therapeutics, Inc.
INSY
$2.36M 0.04%
114,144
+96,645
+552% +$1.92M
VRSN icon
237
VeriSign
VRSN
$25.4B
$2.3M 0.04%
+42,663
New +$2.41M
HRC
238
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$2.3M 0.04%
59,675
-3,092
-5% -$119K
INTC icon
239
Intel
INTC
$436B
$2.29M 0.03%
88,542
+31,869
+56% +$796K
CTXS
240
DELISTED
Citrix Systems Inc
CTXS
$2.29M 0.03%
49,975
-112,400
-69% -$5.3M
ARCB icon
241
ArcBest
ARCB
$3.33B
$2.27M 0.03%
61,521
-196
-0.3% -$6.68K
PVA
242
DELISTED
PENN VIRGINIA CORP
PVA
$2.22M 0.03%
+127,056
New +$1.7M
HPY
243
DELISTED
HEARTLAND PAYMENT SYSTEMS, INC. COM STK
HPY
$2.21M 0.03%
53,372
-10,568
-17% -$459K
F icon
244
Ford
F
$59.2B
$2.19M 0.03%
140,642
-735,500
-84% -$11.4M
WTM icon
245
White Mountains Insurance
WTM
$5.46B
$2.19M 0.03%
+3,656
New +$2.13M
GCAP
246
DELISTED
Gain Capital Holdings, Inc.
GCAP
$2.11M 0.03%
195,423
+53,525
+38% +$523K
SANM icon
247
Sanmina
SANM
$9.06B
$2.11M 0.03%
+120,986
New +$2.03M
MGA icon
248
Magna International
MGA
$18.8B
$2.1M 0.03%
43,600
+1,600
+4% +$71K
ENS icon
249
EnerSys
ENS
$6.61B
$2.07M 0.03%
29,936
+26,978
+912% +$1.89M
SIRO
250
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
$2.06M 0.03%
27,653

Similar funds

Analytic Investors's Q1 2014 Portfolio in Review

As of Q1 2014, Analytic Investors held 665 positions worth $6.57B, up 8.9% from $6.04B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Analytic Investors deployed $353M of net new capital in Q1 2014, opening 181 new positions and adding to 125 existing holdings. Its largest new stake was PARTNERRE LTD: 727,121 shares worth $75.3M.

By sector, the portfolio is most concentrated in Consumer Staples at 19% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Intuitive Surgical, an estimated $61.5M trimmed.

  • Analytic Investors's largest Q1 2014 buy was PARTNERRE LTD: 727,121 shares worth $75.3M.
  • Analytic Investors added most to Merck in Q1 2014, an estimated $103M increase.
  • Analytic Investors's biggest Q1 2014 reduction was Intuitive Surgical, cutting an estimated $61.5M.
  • Analytic Investors fully exited Oracle in Q1 2014, selling an estimated $29.2M.
  • Analytic Investors's ten largest holdings make up 21% of its $6.57B portfolio in Q1 2014.
  • Analytic Investors opened 181 new positions and closed 118 in Q1 2014.
  • Analytic Investors's portfolio value rose 8.9% quarter-over-quarter to $6.57B.

Based on Analytic Investors's 13F filing for Q1 2014, filed 12 May 2014.